Archive for MHRA Updates
Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension, EL(23)A/43
Source: MHRA / Gov.uk 13.12.23 Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not...
Class 4 Medicines Defect Information: Strandhaven Ltd t/a Somex Pharma
Source: MHRA / Gov.uk Patient Information Leaflets (PILs) have been identified in several batches of the following Strandhaven Limited t/a Somex Pharma lines: Clarithromycin 250mg and 500mg film-coated tablets Tramadol...
Pharmacy supervision
Source: DHSC 7.12.23 DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy. This consultation closes at 11:59pm on 29...
Class 4 Medicines Defect Information: Strandhaven Ltd t/a Somex Pharma, Clarithromycin 250mg and 500mg film-coated tablets, EL (23)A/42
Source: MHRA / Gov.uk 8.12.23 Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed...
Class 4 Medicines Defect Information: Strandhaven Ltd t/a Somex Pharma, Tramadol Hydrochloride 50mg Capsules, Hard, EL (23)A/41
Source: MHRA / Gov.uk 8.12.23 Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed...
Class 4 Medicines Defect Information: Strandhaven Ltd t/a Somex Pharma, Tramadol Hydrochloride 50mg Capsules, Hard, EL (23)A/41
Source: MHRA / gov.uk 6.12.23 Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed...
Class 4 Medicines Notification: Teva UK Ltd., Caramet 25/100mg CR Tablets, EL(23)A/40
source: MHRA / Gov.uk 4.12.23 Teva UK Ltd. has informed the MHRA of a labelling error. This notification provides further advice on the safe use of the product. MDR number...
Class 3 Medicines Recall: AstraZeneca UK Ltd., Fluenz Tetra nasal spray suspension, EL(23)A/39
Source: MHRA / Gov.uk 30.11.23 AstraZeneca UK Ltd. has informed the MHRA of an issue related to the expiry dates for certain batches of Fluenz Tetra. This recall provides further...
National Patient Safety Alert: Valproate:
Valproate: organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients (NatPSA/2023/013/MHRA) Source: MHRA/ Gov.uk 28.11.23 The MHRA is asking organisations to...
Specific brands of carbomer eye gel: recall of AACARB eye gel, AACOMER eye gel and PUROPTICS eye gel: potential risk of infection, DSI/2023/11
Source: MHRA/ Gov.uk Specific batches of carbomer gel are being recalled as a precaution due to possible microbiological contamination. Devices Details Device Name: AACARB eye gel, AACOMER eye gel and PUROPTICS...
Treatment with isotretinoin for patients under 18 must be approved by two prescribers, under new MHRA rules
Source: MHRA 31.10.23 New measures strengthen the safe use of the acne drug isotretinoin for patients across the UK, following a patient-focused expert review The UK Medicines and Healthcare products...
#MedSafetyWeek 2023 (6-12 November)
Source: MHRA #MedSafetyWeek is a social media campaign that takes place annually usually in November and each year there is a different focus or theme to encourage the reporting of...
